Strohmaier Stefan, Zwierzchowski Grzegorz
University of Applied Sciences, Technikum Wien Medical Engineering, Vienna, Austria.
J Contemp Brachytherapy. 2011 Dec;3(4):199-208. doi: 10.5114/jcb.2011.26471. Epub 2011 Dec 30.
This paper compares the isotopes (60)Co and (192)Ir as radiation sources for high-dose-rate (HDR) afterloading brachytherapy. The smaller size of (192)Ir sources made it the preferred radionuclide for temporary brachytherapy treatments. Recently also (60)Co sources have been made available with identical geometrical dimensions. This paper compares the characteristics of both nuclides in different fields of brachytherapy based on scientific literature. In an additional part of this paper reports from medical physicists of several radiation therapy institutes are discussed. The purpose of this work is to investigate the advantages or disadvantages of both radionuclides for HDR brachytherapy due to their physical differences. The motivation is to provide useful information to support decision-making procedures in the selection of equipment for brachytherapy treatment rooms. The results of this work show that no advantages or disadvantages exist for (60)Co sources compared to (192)Ir sources with regard to clinical aspects. Nevertheless, there are potential logistical advantages of (60)Co sources due to its longer half-life (5.3 years vs. 74 days), making it an interesting alternative especially in developing countries.
本文比较了作为高剂量率(HDR)后装近距离放射治疗辐射源的同位素钴-60(⁶⁰Co)和铱-192(¹⁹²Ir)。铱-192源尺寸较小,这使其成为临时近距离放射治疗的首选放射性核素。最近,也有几何尺寸相同的钴-60源可供使用。本文基于科学文献比较了这两种核素在近距离放射治疗不同领域的特性。在本文的另一部分,讨论了几个放射治疗机构医学物理学家的报告。这项工作的目的是研究由于这两种放射性核素的物理差异,它们在HDR近距离放射治疗中的优缺点。其动机是提供有用信息,以支持近距离放射治疗室设备选择的决策程序。这项工作的结果表明,就临床方面而言,与铱-192源相比,钴-60源不存在优势或劣势。然而,由于钴-60源半衰期更长(5.3年对74天),在后勤方面具有潜在优势,这使其成为一个有趣的选择,特别是在发展中国家。